These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 33128349)

  • 1. Response to: Is newly diagnosed diabetes a stronger risk factor than pre-existing diabetes for COVID-19 severity?
    Lippi G; Sanchis-Gomar F; Henry BM
    J Diabetes; 2021 Feb; 13(2):179-180. PubMed ID: 33128349
    [No Abstract]   [Full Text] [Related]  

  • 2. Is newly diagnosed diabetes a stronger risk factor than pre-existing diabetes for COVID-19 severity?
    Sathish T; de Mello GT; Cao Y
    J Diabetes; 2021 Feb; 13(2):177-178. PubMed ID: 33107708
    [No Abstract]   [Full Text] [Related]  

  • 3. Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration.
    Fadini GP; Morieri ML; Boscari F; Fioretto P; Maran A; Busetto L; Bonora BM; Selmin E; Arcidiacono G; Pinelli S; Farnia F; Falaguasta D; Russo L; Voltan G; Mazzocut S; Costantini G; Ghirardini F; Tresso S; Cattelan AM; Vianello A; Avogaro A; Vettor R
    Diabetes Res Clin Pract; 2020 Oct; 168():108374. PubMed ID: 32805345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-existing diabetes is worse for SARS-CoV-2 infection; an endothelial perspective.
    La Sala L; Luzi L; Pontiroli AE
    Nutr Metab Cardiovasc Dis; 2020 Sep; 30(10):1855-1856. PubMed ID: 32807635
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of newly diagnosed diabetes on coronavirus disease 2019 severity and hyperglycemia.
    Uchihara M; Bouchi R; Kodani N; Saito S; Miyazato Y; Umamoto K; Sugimoto H; Kobayashi M; Hikida S; Akiyama Y; Ihana-Sugiyama N; Ohsugi M; Tanabe A; Ueki K; Takasaki J; Hojo M; Kajio H
    J Diabetes Investig; 2022 Jun; 13(6):1086-1093. PubMed ID: 35075818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucovigilance in COVID-19.
    Lamptey R; Ahomagnon S; Acheampong F; Kalra S
    J Pak Med Assoc; 2020 May; 70(Suppl 3)(5):S80-S82. PubMed ID: 32515386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of mortality in COVID-19 patients with newly diagnosed and pre-existing diabetes.
    Sathish T
    Prim Care Diabetes; 2022 Feb; 16(1):214. PubMed ID: 34974995
    [No Abstract]   [Full Text] [Related]  

  • 8. Diabetes and COVID-19: Moving From News to Knowledge and a Glucose Hypothesis.
    Riddle MC
    Diabetes Care; 2020 Oct; 43(10):2336-2338. PubMed ID: 32753458
    [No Abstract]   [Full Text] [Related]  

  • 9. Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico.
    Bello-Chavolla OY; Bahena-López JP; Antonio-Villa NE; Vargas-Vázquez A; González-Díaz A; Márquez-Salinas A; Fermín-Martínez CA; Naveja JJ; Aguilar-Salinas CA
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32474598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.
    Zhang JJ; Dong X; Cao YY; Yuan YD; Yang YB; Yan YQ; Akdis CA; Gao YD
    Allergy; 2020 Jul; 75(7):1730-1741. PubMed ID: 32077115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter to the Editor: COVID-19 in patients with diabetes: Risk factors that increase morbidity.
    Klonoff DC; Umpierrez GE
    Metabolism; 2020 Jul; 108():154224. PubMed ID: 32275971
    [No Abstract]   [Full Text] [Related]  

  • 12. Recommendations for the care of patients with diabetes mellitus with risk factors or established cardiovascular disease and SARS-CoV-2mellitus con factores de riesgo o enfermedad cardiovascular establecida y SARS-CoV-2.
    Alcocer-Gamba MA; Gutiérrez-Fajardo P; Sosa-Caballero A; Cabrera-Rayo A; Faradji-Hazan RN; Padilla-Padilla FG; Garnica-Cuellar JC; Hernández-Arispe LM; Reyes-Cianeros FA; León-Suárez A; de-Jesús-Rivera J; Mancillas-Adame L; Gaxiola-Macias M; Márquez-Rodríguez E; Miranda-Malpica E; Sanchez-Pedraza V; Lara-Martínez DS; Segovia-Palomo A; Nava-Hernández A; Rivera-Reyes R
    Arch Cardiol Mex; 2020; 90(Supl):77-83. PubMed ID: 32523151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19.
    Singh AK; Singh R
    Diabetes Res Clin Pract; 2020 Sep; 167():108382. PubMed ID: 32853686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Environmental pollution and COVID-19: the molecular terms and predominant disease outcomes of their sweetheart agreement.
    Colacci A; Bortone G; Maffei G; Marchesi S; Mescoli A; Parmagnani F; Pillo G; Ranzi A; Rotondo F; Serra S; Vaccari M; Zauli Sajani S; Mascolo MG; Jacobs MN
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):169-182. PubMed ID: 33412808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preexisting prediabetes and the severity of COVID-19.
    Sathish T; Cao Y; Kapoor N
    Prim Care Diabetes; 2021 Feb; 15(1):28-29. PubMed ID: 32958435
    [No Abstract]   [Full Text] [Related]  

  • 16. Inflammation and hypercoagulopathy are predominant risk factors of severity in COVID-19 patients with diabetes mellitus: Summary of a meta-analysis.
    Dhar SK; Sachdeva K; Das M
    Diabetes Metab Syndr; 2021; 15(2):639-641. PubMed ID: 33676871
    [No Abstract]   [Full Text] [Related]  

  • 17. Impaired Fasting Glucose and Diabetes Are Related to Higher Risks of Complications and Mortality Among Patients With Coronavirus Disease 2019.
    Zhang J; Kong W; Xia P; Xu Y; Li L; Li Q; Yang L; Wei Q; Wang H; Li H; Zheng J; Sun H; Xia W; Liu G; Zhong X; Qiu K; Li Y; Wang H; Wang Y; Song X; Liu H; Xiong S; Liu Y; Cui Z; Hu Y; Chen L; Pan A; Zeng T
    Front Endocrinol (Lausanne); 2020; 11():525. PubMed ID: 32754119
    [No Abstract]   [Full Text] [Related]  

  • 18. Diabetes mellitus and SARS-CoV-2-related mortality: the impact of acute hyperglycemic crises and some further considerations.
    Patoulias D; Katsimardou A; Papadopoulos C; Doumas M
    Acta Diabetol; 2021 Jan; 58(1):125-126. PubMed ID: 32816107
    [No Abstract]   [Full Text] [Related]  

  • 19. Reply to the letter of Singh and Singh in response to the article: "Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis" (Kumar et al.).
    Kumar A; Arora A; Sharma P; Anikhindi SA; Bansal N; Singla V; Khare S; Srivastava A
    Diabetes Metab Syndr; 2020; 14(5):1147-1148. PubMed ID: 32668400
    [No Abstract]   [Full Text] [Related]  

  • 20. Age but not sex may explain the negative effect of arterial hypertension and diabetes on COVID-19 prognosis.
    Pirola CJ; Sookoian S
    J Infect; 2020 Oct; 81(4):647-679. PubMed ID: 32407757
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.